- Home
- CXAI vs EVAX Comparison
CXAI vs EVAX Comparison
Compare CXAI & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- EVAX
- Stock Information
- Founded
- CXAI N/A
- EVAX 2008
- Country
- CXAI United States
- EVAX Denmark
- Employees
- CXAI N/A
- EVAX N/A
- Industry
- CXAI EDP Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CXAI Technology
- EVAX Health Care
- Exchange
- CXAI Nasdaq
- EVAX Nasdaq
- Market Cap
- CXAI 16.0M
- EVAX 17.8M
- IPO Year
- CXAI N/A
- EVAX 2021
- Fundamental
- Price
- CXAI $0.76
- EVAX $2.94
- Analyst Decision
- CXAI
- EVAX Strong Buy
- Analyst Count
- CXAI 0
- EVAX 2
- Target Price
- CXAI N/A
- EVAX $10.00
- AVG Volume (30 Days)
- CXAI 640.1K
- EVAX 88.6K
- Earning Date
- CXAI 11-11-2025
- EVAX 10-30-2025
- Dividend Yield
- CXAI N/A
- EVAX N/A
- EPS Growth
- CXAI N/A
- EVAX N/A
- EPS
- CXAI N/A
- EVAX N/A
- Revenue
- CXAI $6,005,000.00
- EVAX $3,176,000.00
- Revenue This Year
- CXAI N/A
- EVAX N/A
- Revenue Next Year
- CXAI $60.00
- EVAX N/A
- P/E Ratio
- CXAI N/A
- EVAX N/A
- Revenue Growth
- CXAI N/A
- EVAX 1042.45
- 52 Week Low
- CXAI $0.61
- EVAX $1.20
- 52 Week High
- CXAI $2.54
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- CXAI 46.64
- EVAX 52.59
- Support Level
- CXAI $0.66
- EVAX $2.71
- Resistance Level
- CXAI $0.74
- EVAX $3.04
- Average True Range (ATR)
- CXAI 0.05
- EVAX 0.19
- MACD
- CXAI 0.01
- EVAX -0.02
- Stochastic Oscillator
- CXAI 70.19
- EVAX 57.53
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.